In vitro biophysical and pharmacological profiling predicts in vivo efficacy of anti-carfentanil monoclonal antibodies in mice
Biochemical and Biophysical Research Communications · 2025
DOI: 10.1016/j.bbrc.2025.151995 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2025. Verfasst von Brooke K Hoppe und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle, WA, 98104, USA. Hauptthemen laut MEDLINE: Fentanyl, Antibodies, Monoclonal, Respiratory Insufficiency, Analgesics, Opioid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: NIDA NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Synthetic opioids, including fentanyl and its potent analogs (F/FA) such as carfentanil, are involved in the majority of fatal and non-fatal overdoses in the United States. Despite the availability of the opioid receptor antagonists naloxone and nalmefene to treat overdose, this public health crisis highlights the need for a broader range of treatment options. To support the clinical value of drug-specific monoclonal antibodies (mAbs) as therapeutics for reducing opioid overdose toxicity, the current studies performed in vitro characterization of anti-carfentanil mAbs, and in vivo assessment of their efficacy against carfentanil-induced respiratory depression in mice. To probe the binding interaction between mAbs and carfentanil, this study employed a human mu-opioid receptor (hMOR) calcium mobilization assay and differential scanning fluorimetry. Two of the five mAbs significantly reversed carfentanil-induced respiratory depression in mice. The degree of thermal stabilization of carfentanil-bound mAb correlated with greater efficacy of a given mAb to reverse carfentanil-induced respiratory depression in mice. The reduction of carfentanil-induced hMOR activation stratified mAbs into categories that corresponded, albeit not significantly, to greater in vivo efficacy. These studies indicate that biophysical and pharmacological in vitro analyses can predict the in vivo efficacy of novel mAbs, and support further investigation of mAb-based therapeutics against carfentanil toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle, WA, 98104, USA.
- Center for Drug Discovery, Research Triangle Institute International, Research Triangle Park, NC, 27709, USA.
- Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN, 55455, USA.
- Department of Microbiology and Immunology, University of Nevada Reno, Reno, NV, 89557, USA.
- Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle, WA, 98104, USA; Department of Pharmacology, School of Medicine, University of Washington, Seattle, WA, 98104, USA;…
Förderung
- NIDA NIH HHS
- National Institutes of Health
Zitieren
APA
Hoppe, B. K., Seaman, R. W., Hannon, B., Gay, E., Hicks, D., Baehr, C., Hill, H. J., Pandit, S. G., Baldridge, A., Berner, V., AuCoin, D. P., Runyon, S., & Pravetoni, M. (2025). In vitro biophysical and pharmacological profiling predicts in vivo efficacy of anti-carfentanil monoclonal antibodies in mice. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2025.151995
Vancouver
Hoppe BK, Seaman RW, Hannon B, Gay E, Hicks D, Baehr C, et al. In vitro biophysical and pharmacological profiling predicts in vivo efficacy of anti-carfentanil monoclonal antibodies in mice. Biochemical and Biophysical Research Communications. 2025. doi:10.1016/j.bbrc.2025.151995
BibTeX
@article{Hoppe2025,
author = {Hoppe, Brooke K and Seaman, Robert W and Hannon, Bryan and Gay, Elaine and Hicks, Dustin and Baehr, Carly and Hill, Haydon J and Pandit, Sujata G and Baldridge, Austin and Berner, Vanessa and AuCoin, David P and Runyon, Scott and Pravetoni, Marco},
title = {In vitro biophysical and pharmacological profiling predicts in vivo efficacy of anti-carfentanil monoclonal antibodies in mice},
journal = {Biochemical and Biophysical Research Communications},
year = {2025},
doi = {10.1016/j.bbrc.2025.151995}
}
EUVIMED